Paul Averback
Förmögenhet: 4 M $ per 2025-06-30
Förmögenhet: 4 M $ per 2025-06-30
Paul Averback is the founder of Nymox Pharmaceutical Corp.
since 1995, holding the title of Co-Chairman, President & Chief Executive Officer.
Former job includes President at DMS Pharmaceutical Group, Inc. Education includes a doctorate from the University of Cambridge, conferred in 1975.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NYMOX PHARMACEUTICAL CORP 37,43 % | 2025-04-19 | 35 008 010 ( 37,43 % ) | 4 M $ | 2025-06-30 |
| Företag | Position | Start |
|---|---|---|
| NYMOX PHARMACEUTICAL CORPORATION | Verkställande Direktör | 1995-09-30 |
| Företag | Position | Slut |
|---|---|---|
DMS Pharmaceutical Group, Inc.
DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services Supplies pharmaceutical products | President | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Nymox Pharmaceutical Corp.
Nymox Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which specializes in the research and development of products for the aging population | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DMS Pharmaceutical Group, Inc.
DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån